Skip to main content
Equibles

PNC FINANCIAL SERVICES GROUP, INC.

Position in ANIX — Anixa Biosciences Inc

CIK 713676 Pittsburgh, PA
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$8,509
+$669 QoQ
Shares Held
3,039
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 62 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,432,736 across 262 Biotechnology names. ANIX ranks #145 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 69,358 $34,452,195
2 REGN
Regeneron Pharmaceuticals, Inc.
 16,662 $10,389,420
3 TECH
BIO-TECHNE Corp
 77,074 $5,445,277
4 MRNA
Moderna, Inc.
 70,829 $4,960,151
5 TGTX
Tg Therapeutics, Inc.
 89,646 $4,925,149
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 39,473 $3,847,827
7 INCY
Incyte Corp
 32,777 $3,715,597
8 ARGX
Argenx SE
 3,967 $3,680,460

All Filings in ANIX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,509 3,039
2026-03-31 $7,840 3,039
2025-12-31 $9,481 3,039
2025-09-30 $10,028 3,039
2025-06-30 $10,028 3,039
2025-03-31 $8,691 3,039
2024-12-31 $7,050 3,039
2024-09-30 $9,572 3,039
2024-06-30 $6,716 3,039
2024-03-31 $10,105 3,239
2023-12-31 $11,791 3,039
2023-09-30 $9,937 3,039